These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31780076)

  • 1. Long-Term Efficacy of Extended Dual Antiplatelet Therapy After Left Main Coronary Artery Bifurcation Stenting.
    Cho S; Kim JS; Kang TS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Song YB; Hahn JY; Choi SH; Gwon HC; Hong MK; Jang Y
    Am J Cardiol; 2020 Feb; 125(3):320-327. PubMed ID: 31780076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II.
    Jang WJ; Ahn SG; Song YB; Choi SH; Chun WJ; Oh JH; Cho SW; Kim BS; Yoon JH; Koo BK; Yu CW; Jang YS; Tahk SJ; Kim HS; Gwon HC; Lee SY; Hahn JY
    Circ Cardiovasc Interv; 2018 Jul; 11(7):e005849. PubMed ID: 30006330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis.
    Lee OH; Kim BK; Hong SJ; Kim S; Ahn CM; Shin DH; Kim JS; Kang TS; Ko YG; Choi D; Hong MK; Jang Y
    Yonsei Med J; 2020 Jul; 61(7):597-605. PubMed ID: 32608203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry).
    De Filippo O; Kang J; Bruno F; Han JK; Saglietto A; Yang HM; Patti G; Park KW; Parma R; Kim HS; De Luca L; Gwon HC; Iannaccone M; Chun WJ; Smolka G; Hur SH; Cerrato E; Han SH; di Mario C; Song YB; Escaned J; Choi KH; Helft G; Doh JH; Truffa Giachet A; Hong SJ; Muscoli S; Nam CW; Gallone G; Capodanno D; Trabattoni D; Imori Y; Dusi V; Cortese B; Montefusco A; Conrotto F; Colonnelli I; Sheiban I; de Ferrari GM; Koo BK; D'Ascenzo F
    Am J Cardiol; 2021 Oct; 156():16-23. PubMed ID: 34353628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease.
    Cho S; Kang DY; Kim JS; Park DW; Kim IS; Kang TS; Ahn JM; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Jang Y; Hong MK; Park SJ
    Rev Esp Cardiol (Engl Ed); 2023 Apr; 76(4):245-252. PubMed ID: 35907438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple versus dual antiplatelet therapy after percutaneous coronary intervention for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II Registry.
    Song PS; Song YB; Yang JH; Hahn JY; Choi SH; Choi JH; Lee SH; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    Heart Vessels; 2015 Jul; 30(4):458-68. PubMed ID: 24682436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Duration for Dual Antiplatelet Therapy After Left Main Coronary Artery Stenting.
    Choi J; Kim IS; Cho S; Kim JS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    Circ J; 2020 Dec; 85(1):59-68. PubMed ID: 33281141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.
    Song YB; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Lee JH; Yu CW; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Oh JH; Park JS; Gwon HC
    JACC Cardiovasc Interv; 2014 Mar; 7(3):255-63. PubMed ID: 24529936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
    Ohya M; Kadota K; Toyofuku M; Morimoto T; Higami H; Fuku Y; Yamaji K; Muranishi H; Yamaji Y; Nishida K; Furukawa D; Tada T; Ko E; Ando K; Sakamoto H; Tamura T; Kawai K; Kimura T;
    Am J Cardiol; 2017 Feb; 119(3):355-364. PubMed ID: 27887688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations.
    D'Ascenzo F; Barbero U; Abdirashid M; Trabattoni D; Boccuzzi G; Ryan N; Quadri G; Capodanno D; Venuti G; Muscoli S; Tomassini F; Autelli M; Montabone A; Wojakowski W; Rognoni A; Gallo D; Parma R; De Luca L; Figini F; Mitomo S; Montefusco A; Mattesini A; Wańha W; Protasiewicz M; Smolka G; Huczek Z; Rolfo C; Cortese B; Chieffo A; Kuliczowki W; Nuñez-Gil I; Morbiducci U; Ugo F; Marengo G; Iannaccone M; Cerrato E; Mario CD; Moretti C; D'Amico M; Varbella F; Lüscher TF; Sheiban I; Escaned J; Romeo F; Rinaldi M; De Ferrari GM; Helft G
    Am J Cardiol; 2020 Feb; 125(4):491-499. PubMed ID: 31889527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting.
    Cho S; Kang TS; Kim JS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Song YB; Hahn JY; Choi SH; Gwon HC; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1247-1258. PubMed ID: 29976361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Kim HS; Valgimigli M; Palmerini T; Stone GW
    Clin Res Cardiol; 2017 Mar; 106(3):165-173. PubMed ID: 27631821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry.
    Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Seong IW; Yang JY; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Park SJ; Gwon HC
    J Am Coll Cardiol; 2010 Apr; 55(16):1743-50. PubMed ID: 20394879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term outcomes after percutaneous interventions in coronary bifurcations.
    Zimarino M; Briguori C; Amat-Santos IJ; Radico F; Barbato E; Chieffo A; Cirillo P; Costa RA; Erglis A; Gamra H; Gil RJ; Kanic V; Kedev SA; Maddestra N; Nakamura S; Pellicano M; Petrov I; Strozzi M; Tesorio T; Vukcevic V; De Caterina R; Stankovic G;
    Int J Cardiol; 2019 May; 283():78-83. PubMed ID: 30528620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
    Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
    J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus.
    Wang HY; Cai ZX; Yin D; Yang YJ; Song WH; Dou KF
    Am J Cardiol; 2021 Mar; 142():14-24. PubMed ID: 33285091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
    Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Prolonged Dual Antiplatelet Therapy After Bifurcation Percutaneous Coronary Intervention in Patients with High Ischemic Risk.
    Khelimskii D; Bessonov I; Sapozhnikov S; Badoyan A; Baranov A; Mamurjon M; Manukian S; Utegenov R; Krestyaninov O
    Am J Cardiovasc Drugs; 2024 Jul; 24(4):577-588. PubMed ID: 38871947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transradial versus transfemoral intervention for the treatment of left main coronary bifurcations: results from the COBIS (COronary BIfurcation Stenting) II Registry.
    Chung S; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Jang Y; Yoon JH; Tahk SJ; Seung KB; Gwon HC
    J Invasive Cardiol; 2015 Jan; 27(1):35-40. PubMed ID: 25589699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.